Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2008-03-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Plasma EBV DNA Monitoring in Post-treatment NPC Patients
NCT03973723
Human Papillomavirus on Oral Tissue, Saliva and Serum
NCT01043328
Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma
NCT03087695
Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening
NCT06971276
Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer
NCT04566367
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
oral cancer
patients with oral squamous cell carcinoma
No interventions assigned to this group
control group
healthy patients without any oral pathology
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with oral squamous cell carcinoma
Exclusion Criteria
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UPECLIN HC FM Botucatu Unesp
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Glauco Issamu I Miyahara, Professor
Role: PRINCIPAL_INVESTIGATOR
Department of Pathology and Propaedeutics, Sao Paulo State University, Unesp, Araçatuba/SP
Lívia T Arêde, student
Role: STUDY_CHAIR
Department of Pathology and Propaedeutics, Sao Paulo State University, Unesp, Araçatuba/SP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Pathology and Propaedeutics, Sao Paulo State University, Unesp, Araçatuba/SP
Araçatuba, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
School of Dentistry, Sao Paulo State University, Unesp, Araçatuba/SP
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
upeclin/FOA-Unesp-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.